BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gowen AM, Odegaard KE, Hernandez J, Chand S, Koul S, Pendyala G, Yelamanchili SV. Role of microRNAs in the pathophysiology of addiction. Wiley Interdiscip Rev RNA 2021;12:e1637. [PMID: 33336550 DOI: 10.1002/wrna.1637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Deveci E, Akbaş F, Ergun AŞ, Kurtulmuş A, Koçak AB, Boyraz RK, Tok OE, Aydın MŞ, Kılıç Ö, Bozkurt A, Uysal Ö, Eşrefoğlu M, Koçyiğit A, Öztürk A, Lawrence AJ, Kırpınar I. The Effects of Transcranial Focused Ultrasound Stimulation of Nucleus Accumbens on Neuronal Gene Expression and Brain Tissue in High Alcohol-Preferring Rats. Mol Neurobiol 2023;60:1099-116. [PMID: 36417101 DOI: 10.1007/s12035-022-03130-9] [Reference Citation Analysis]
2 Jarczak J, Miszczak M, Radwanska K. Is DNA methylation in the brain a mechanism of alcohol use disorder? Front Behav Neurosci 2023;17. [DOI: 10.3389/fnbeh.2023.957203] [Reference Citation Analysis]
3 Grimm SL, Mendez EF, Stertz L, Meyer TD, Fries GR, Gandhi T, Kanchi R, Selvaraj S, Teixeira AL, Kosten TR, Gunaratne P, Coarfa C, Walss-Bass C. MicroRNA-mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations. Front Psychiatry 2022;13:1025346. [PMID: 36713930 DOI: 10.3389/fpsyt.2022.1025346] [Reference Citation Analysis]
4 Cabana-Domínguez J, Antón-Galindo E, Fernàndez-Castillo N, Singgih EL, O'Leary A, Norton WH, Strekalova T, Schenck A, Reif A, Lesch KP, Slattery D, Cormand B. The translational genetics of ADHD and related phenotypes in model organisms. Neurosci Biobehav Rev 2023;144:104949. [PMID: 36368527 DOI: 10.1016/j.neubiorev.2022.104949] [Reference Citation Analysis]
5 Fauser AM, Stidham E, Cady C, Gupta A. Role of microRNA-132 in Opioid Addiction through Modification of Neural Stem Cell Differentiation. J Pers Med 2022;12. [PMID: 36579528 DOI: 10.3390/jpm12111800] [Reference Citation Analysis]
6 Mazdai L, Fabbri M, Tirri M, Corli G, Arfè R, Marchetti B, Bilel S, Bergamin E, Gaudio RM, Rubini M, De-giorgio F, Marti M. Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones. Biomedicines 2022;10:1398. [DOI: 10.3390/biomedicines10061398] [Reference Citation Analysis]
7 Deng B, Zhang Z, Zhou H, Zhang X, Niu S, Yan X, Yan J. MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction. Front Pharmacol 2022;13:875666. [DOI: 10.3389/fphar.2022.875666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kim B, Tag SH, Nam E, Ham S, Ahn S, Kim J, Cho D, Lee S, Yang Y, Lee SE, Kim YS, Cho I, Kim KP, Han S, Im H. SYNCRIP controls miR-137 and striatal learning in animal models of methamphetamine abstinence. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Purohit P, Roy D, Dwivedi S, Nebhinani N, Sharma P. Association of miR-155, miR-187 and Inflammatory Cytokines IL-6, IL-10 and TNF-α in Chronic Opium Abusers. Inflammation. [DOI: 10.1007/s10753-021-01566-0] [Reference Citation Analysis]
10 Seyednejad SA, Sartor GC. Noncoding RNA therapeutics for substance use disorder. Adv Drug Alcohol Res 2022;2:10807. [PMID: 36601439 DOI: 10.3389/adar.2022.10807] [Reference Citation Analysis]
11 Das T, Das TK, Khodarkovskaya A, Dash S. Non-coding RNAs and their bioengineering applications for neurological diseases. Bioengineered 2021. [PMID: 34756133 DOI: 10.1080/21655979.2021.2003667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Lenoir M, Bondi I, Clemenceau L, Nondier I, Ballé M, Jacques S, Duché A, Canestrelli C, Martin-lannerée S, Mouillet-richard S, Gunnersen JM, Ahmed SH, Marie N, Noble F. Inhibition of striatal SEZ6 by miR-3594-5p is a drug-specific marker for late-stage heroin intake escalation.. [DOI: 10.1101/2021.07.26.453355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cormand B, Cabana-Domínguez J, Forero DA, Fernàndez-Castillo N. Genomics and epigenomics of substance use disorders: An introduction. Am J Med Genet B Neuropsychiatr Genet 2021;186:125-7. [PMID: 33973715 DOI: 10.1002/ajmg.b.32844] [Reference Citation Analysis]